Premium
Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome
Author(s) -
Vetro Calogero,
Rosso Rosamaria,
Palmucci Stefano,
Russello Maurizio,
Colletta Grazia,
Romeo Maria Anna,
Ximenes Benedetta,
Romano Alessandra,
Palumbo Giuseppe Alberto,
Di Raimondo Francesco
Publication year - 2016
Publication title -
journal of clinical apheresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.697
H-Index - 46
eISSN - 1098-1101
pISSN - 0733-2459
DOI - 10.1002/jca.21434
Subject(s) - medicine , apheresis , intensive care medicine , pediatrics , platelet
Dysmetabolic iron overload syndrome is a rare event causing hepatic impairment with serious long‐term side effects. Here, we describe a case of metabolic syndrome‐related hepatic iron overload that showed a rapid, effective, and safe response to erythrocytapheresis. J. Clin. Apheresis 31:443–447, 2016. © 2015 Wiley Periodicals, Inc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom